BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

In sporadic epithelial ovarian cancer (EOC), the inactivation of BRCA1 through various mechanisms is a relatively common event. BRCA1 protein dysfunction results in the breakdown of various critical pathways in the cell, notably, the DNA damage response and repair pathway. Tumors from patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark-Knowles, Katherine V., O'Brien, Anna M., Weberpals, Johanne I.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825770/
https://www.ncbi.nlm.nih.gov/pubmed/20182637
http://dx.doi.org/10.1155/2010/891059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825770/
https://www.ncbi.nlm.nih.gov/pubmed/20182637
http://dx.doi.org/10.1155/2010/891059

Ejemplares similares